Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 2400Neoplasms 1819Carcinoma, Non-Small-Cell Lung 1599Prostatic Neoplasms 1298Colorectal Neoplasms 1140Lung Neoplasms 984Neoplasm Metastasis 830Multiple Myeloma 792Leukemia, Myeloid, Acute 767Ovarian Neoplasms 674Pancreatic Neoplasms 662Melanoma 660Squamous Cell Carcinoma of Head and Neck 586Carcinoma, Hepatocellular 567Recurrence 562Brain Neoplasms 527Glioblastoma 513Head and Neck Neoplasms 500Stomach Neoplasms 497Triple Negative Breast Neoplasms 465Lymphoma 454Uterine Cervical Neoplasms 450Carcinoma, Renal Cell 425Precursor Cell Lymphoblastic Leukemia-Lymphoma 410Lymphoma, Non-Hodgkin 389Endometrial Neoplasms 381Sarcoma 368Lymphoma, Follicular 356Urinary Bladder Neoplasms 354Hematologic Neoplasms 352

Interventions

Fecal Microbiota Transplantation 2Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Solid Carcinoma × 1 year × Clear all
NCT04264975 2026-05-22

Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology

Asan Medical Center

Phase NA Recruiting
60 enrolled

Solid Carcinoma

NCT06051214 2026-02-17

THROMBIN

Institut Cancerologie de l'Ouest

Phase NA Recruiting
200 enrolled

Solid Carcinoma

NCT05533983 2025-12-03

NIVO-FMT

Asan Medical Center

Phase NA Recruiting
50 enrolled

Solid Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡